Harvard Bioscience

$6.90 0.00% ($0.00)
  • 1D
  • 1W
  • 1M
  • 1Y
  • 5Y
  • YTD

Get ready to invest

Subscribe

About Harvard Bioscience

Harvard Bioscience, Inc. develops, manufactures, and markets tools used in drug discovery research and pharmaceutical and biotechnology companies, universities, and government laboratories. The Company's tools include proteomics products that allow researchers to purify and analyze proteins and ADMET screening products that test drug candidates.

Stock Analysis

last close $6.9
1-mo return -3.4%
3-mo return -15.2%
avg daily vol. 144.24T
52-week high 8.75
52-week low 3.74
market cap. $304M
forward pe 21.9
annual div. -
roe -2.4%
ltg forecast -
dividend yield -
annual rev. $117M
inst own. 75.9%
baraka

Subscribe now for daily local and international financial news

Subscribe